All

Emerging Treatment Approaches of High-Risk Myelodysplastic Syndrome

The Stanford University Cancer Center and the MDS Foundation are proud to bring you this complimentary webinar presented by Stanford’s Dr. Michael Spinner, post-doctoral medical fellow, oncology, and moderated by the MDS Foundation’s Sandra Kurtin, Ph.D., ANP-C, AOCN.

View Webinar

First Name*
Last Name
Email Address*
Phone Number
Company Name*
I am interested in*
Additional comments or questions
If you are a patient or family member of a patient, we encourage you to discuss all of your treatment options with your physician. If, after discussion with your physician, you would like more information about Notable, please have your physician contact us using the form on this page.
Consent*
I agree to receiving news and updates from Notable
CAPTCHA
Email
This field is for validation purposes and should be left unchanged.

PRESS RELEASE

Notable Labs Presents Data Demonstrating PPMP’s Potential to Identify Novel Drug Combinations in JMML at the 2023 EHA Hybrid Congress

Notable News

Emerging Treatment Approaches of High-Risk Myelodysplastic Syndrome

View Webinar

Connect with us